【問題】transcend trial ?推薦回答
關於「transcend trial」標籤,搜尋引擎有相關的訊息討論:
Study Evaluating the Safety and Pharmacokinetics of JCAR017 in B ...。
Salvage Chemotherapy in Diffuse Large B-Cell Lymphoma: TRANSCEND vs. ... costs in lisocabtagene maraleucel-treated patients in the TRANSCEND NHL 001 trial.: tw | tw。
Pivotal Safety and Efficacy Results from Transcend NHL 001, a ...。
2019年11月13日 · Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)-Results from Prospective Clinical Trials| ...: 。
Updated safety and long term clinical outcomes in TRANSCEND ...。
2018年6月1日 · A multicenter seamless design pivotal phase 1 trial of liso-cel in R/R ... NOS (de novo or transformed from FL) and high grade lymphoma.。
High durable CR rates and preliminary safety profile for JCAR017 in ...。
2018年2月26日 · ... trial of relapsed/refractory (R/R) B-cell NHL (TRANSCEND NHL 001; NCT02631044). Methods: Patients (pts) with R/R DLBCL NOS, PMBCL, FL ...。
Transcend - 創見資訊。
: trial? 。
Telmisartan Randomised Assessment Study in ACE Intolerant ...。
2009年7月23日 · The TRANSCEND Study: A Randomized Placebo-Controlled Clinical Trial Evaluating the Effects of Telmisartan in High Risk Individuals Without Heart ...: 。
61st ASH Annual Meeting - Twitter。
Conclusion: tazemetostat has single agent activity in R/R FL including in ... is prognostic in patients treated in the GALLIUM trial receiving R-CHOP/CVP ...。
Liso-cel updates from TRANSCEND-CLL-004 and TRANCEND ...。
2021年2月17日 · TRANSCEND-CLL-004 (NCT03331198) is a phase I/II trial ... Grade 3B follicular lymphoma (FL), or primary mediastinal large B-cell lymphoma ...: tw | tw。
Recent Advances in the Pathogenesis, Prevention and Management of ...。
[114] Sowers JR, Neutel JM, Saunders E, Bakris GL, Cushman WC, Ferdinand KC ... into hypertension guidelines: the case of the ONTARGET and TRANSCEND trials.。
Relative and Combined Prognostic Importance of On-Treatment ...。
2017年10月3日 · Briefly, both ONTARGET and TRANSCEND were multicenter trials that enrolled patients with known atherosclerotic disease (myocardial infarction, ...
常見transcend trial問答
延伸文章資訊Clinical trials of angiotensin-converting enzyme (ACE) inhibitors and ... combination with Ramipr...
... in high-risk patients: results from ONTARGET and TRANSCEND trials ... The Systolic blood Pres...
The ONTARGET (Ongoing Telmisartan Alone and in Combination With Ramipril Global End Point Trial) ...
Large-scale cardiovascular trials traditionally have targeted clinical ... with Ramipril Global E...
The ONTARGET Trial Programme includes the ONTARGET and TRANSCEND studies. In both studies, partic...
The 2008 Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial (ONTARG...
... Alone and in combination with Ramipril Global Endpoint Trial - ONTARGET ... Trial Sponsor: Bo...
The Ongoing Telmisartan Alone and combination with Ramipril global Endpoint trial (ONTARGET). Tim...
Clinical trials of angiotensin-converting enzyme (ACE) inhibitors and ... combination with Ramipr...
... in high-risk patients: results from ONTARGET and TRANSCEND trials ... The Systolic blood Pres...
The ONTARGET (Ongoing Telmisartan Alone and in Combination With Ramipril Global End Point Trial) ...
Large-scale cardiovascular trials traditionally have targeted clinical ... with Ramipril Global E...
The ONTARGET Trial Programme includes the ONTARGET and TRANSCEND studies. In both studies, partic...
The 2008 Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial (ONTARG...
... Alone and in combination with Ramipril Global Endpoint Trial - ONTARGET ... Trial Sponsor: Bo...
The Ongoing Telmisartan Alone and combination with Ramipril global Endpoint trial (ONTARGET). Tim...